Literature DB >> 28539455

Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.

Nicolas Lévêque1,2, Magali Garcia3, Alexis Bouin2, Joseph H C Nguyen2, Genevieve P Tran2, Laurent Andreoletti4, Bert L Semler5.   

Abstract

Group B coxsackieviruses are responsible for chronic cardiac infections. However, the molecular mechanisms by which the virus can persist in the human heart long after the signs of acute myocarditis have abated are still not completely understood. Recently, coxsackievirus B3 strains with 5'-terminal deletions in genomic RNAs were isolated from a patient suffering from idiopathic dilated cardiomyopathy, suggesting that such mutant viruses may be the forms responsible for persistent infection. These deletions lacked portions of 5' stem-loop I, which is an RNA secondary structure required for viral RNA replication. In this study, we assessed the consequences of the genomic deletions observed in vivo for coxsackievirus B3 biology. Using cell extracts from HeLa cells, as well as transfection of luciferase replicons in two types of cardiomyocytes, we demonstrated that coxsackievirus RNAs harboring 5' deletions ranging from 7 to 49 nucleotides in length can be translated nearly as efficiently as those of wild-type virus. However, these 5' deletions greatly reduced the synthesis of viral RNA in vitro, which was detected only for the 7- and 21-nucleotide deletions. Since 5' stem-loop I RNA forms a ribonucleoprotein complex with cellular and viral proteins involved in viral RNA replication, we investigated the binding of the host cell protein PCBP2, as well as viral protein 3CDpro, to deleted positive-strand RNAs corresponding to the 5' end. We found that binding of these proteins was conserved but that ribonucleoprotein complex formation required higher PCBP2 and 3CDpro concentrations, depending on the size of the deletion. Overall, this study confirmed the characteristics of persistent CVB3 infection observed in heart tissues and provided a possible explanation for the low level of RNA replication observed for the 5'-deleted viral genomes-a less stable ribonucleoprotein complex formed with proteins involved in viral RNA replication.IMPORTANCE Dilated cardiomyopathy is the most common indication for heart transplantation worldwide, and coxsackie B viruses are detected in about one-third of idiopathic dilated cardiomyopathies. Terminal deletions at the 5' end of the viral genome involving an RNA secondary structure required for RNA replication have been recently reported as a possible mechanism of virus persistence in the human heart. These mutations are likely to disrupt the correct folding of an RNA secondary structure required for viral RNA replication. In this report, we demonstrate that transfected RNAs harboring 5'-terminal sequence deletions are able to direct the synthesis of viral proteins, but not genomic RNAs, in human and murine cardiomyocytes. Moreover, we show that the binding of cellular and viral replication factors to viral RNA is conserved despite genomic deletions but that the impaired RNA synthesis associated with terminally deleted viruses could be due to destabilization of the ribonucleoprotein complexes formed.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  RNA replication; cardiomyocytes; coxsackievirus; enterovirus; genomic RNA deletions; myocarditis; picornavirus; viral pathogenesis; viral persistence; viral translation

Mesh:

Substances:

Year:  2017        PMID: 28539455      PMCID: PMC5533909          DOI: 10.1128/JVI.00423-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis.

Authors:  J Herold; R Andino
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group.

Authors:  S Rakar; G Sinagra; A Di Lenarda; A Poletti; R Bussani; F Silvestri; F Camerini
Journal:  Eur Heart J       Date:  1997-01       Impact factor: 29.983

3.  Cerebrospinal fluid detection of enterovirus genome in ALS: a study of 242 patients and 354 controls.

Authors:  Nadia Vandenberghe; Nicolas Leveque; Philippe Corcia; Véronique Brunaud-Danel; Emmanuelle Salort-Campana; Gérard Besson; Christine Tranchant; Pierre Clavelou; Frédérique Beaulieux; René Ecochard; Christophe Vial; Emmanuel Broussolle; Bruno Lina
Journal:  Amyotroph Lateral Scler       Date:  2010-05-03

Review 4.  The group B coxsackieviruses and myocarditis.

Authors:  K S Kim; G Hufnagel; N M Chapman; S Tracy
Journal:  Rev Med Virol       Date:  2001 Nov-Dec       Impact factor: 6.989

5.  Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment.

Authors:  Matthew S Barnabei; Frances V Sjaastad; DeWayne Townsend; Fikru B Bedada; Joseph M Metzger
Journal:  Sci Transl Med       Date:  2015-07-01       Impact factor: 17.956

6.  5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.

Authors:  K-S Kim; S Tracy; W Tapprich; J Bailey; C-K Lee; K Kim; W H Barry; N M Chapman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 7.  Coxsackievirus B RNA replication: lessons from poliovirus.

Authors:  P Sean; B L Semler
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

Review 8.  Interferon-stimulated genes and their antiviral effector functions.

Authors:  John W Schoggins; Charles M Rice
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

9.  Major Persistent 5' Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues.

Authors:  Alexis Bouin; Yohan Nguyen; Michel Wehbe; Fanny Renois; Paul Fornes; Firouze Bani-Sadr; Damien Metz; Laurent Andreoletti
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883

Review 10.  Acute viral myocarditis.

Authors:  Robert Dennert; Harry J Crijns; Stephane Heymans
Journal:  Eur Heart J       Date:  2008-07-09       Impact factor: 29.983

View more
  14 in total

1.  Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.

Authors:  Claudia T Flynn; Taishi Kimura; Kwesi Frimpong-Boateng; Stephanie Harkins; J Lindsay Whitton
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

2.  Profiling of rotavirus 3'UTR-binding proteins reveals the ATP synthase subunit ATP5B as a host factor that supports late-stage virus replication.

Authors:  Lili Ren; Siyuan Ding; Yanhua Song; Bin Li; Muthukumar Ramanathan; Julia Co; Manuel R Amieva; Paul A Khavari; Harry B Greenberg
Journal:  J Biol Chem       Date:  2019-02-15       Impact factor: 5.157

Review 3.  Emergency Services of Viral RNAs: Repair and Remodeling.

Authors:  Vadim I Agol; Anatoly P Gmyl
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-14       Impact factor: 11.056

4.  Persistent Infection and Transmission of Senecavirus A from Carrier Sows to Contact Piglets.

Authors:  Mayara F Maggioli; Maureen H V Fernandes; Lok R Joshi; Bishwas Sharma; Megan M Tweet; Jessica C G Noll; Fernando V Bauermann; Diego G Diel
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

5.  Cellular Protein HuR Regulates the Switching of Genomic RNA Templates for Differential Functions during the Coxsackievirus B3 Life Cycle.

Authors:  Pratik Dave; Priya Rani; Biju George; Padmanava Behera; Saumitra Das
Journal:  J Virol       Date:  2021-08-18       Impact factor: 5.103

Review 6.  Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset.

Authors:  Zachary J Morse; Marc S Horwitz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-26       Impact factor: 5.555

Review 7.  Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.

Authors:  Carsten Tschöpe; Enrico Ammirati; Biykem Bozkurt; Alida L P Caforio; Leslie T Cooper; Stephan B Felix; Joshua M Hare; Bettina Heidecker; Stephane Heymans; Norbert Hübner; Sebastian Kelle; Karin Klingel; Henrike Maatz; Abdul S Parwani; Frank Spillmann; Randall C Starling; Hiroyuki Tsutsui; Petar Seferovic; Sophie Van Linthout
Journal:  Nat Rev Cardiol       Date:  2020-10-12       Impact factor: 49.421

Review 8.  Structures and Functions of Viral 5' Non-Coding Genomic RNA Domain-I in Group-B Enterovirus Infections.

Authors:  Marie Glenet; Laetitia Heng; Domitille Callon; Anne-Laure Lebreil; Paul-Antoine Gretteau; Yohan Nguyen; Fatma Berri; Laurent Andreoletti
Journal:  Viruses       Date:  2020-08-21       Impact factor: 5.048

Review 9.  Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?

Authors:  Kasper Favere; Matthias Bosman; Karin Klingel; Stephane Heymans; Sophie Van Linthout; Peter L Delputte; Johan De Sutter; Hein Heidbuchel; Pieter-Jan Guns
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

Review 10.  The long-lasting enigma of polycytidine (polyC) tract.

Authors:  Velia Penza; Stephen J Russell; Autumn J Schulze
Journal:  PLoS Pathog       Date:  2021-08-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.